dexamethasone 21-phosphate has been researched along with Uveitis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, Z; Duh, EJ; Eberhart, CG; Ensign, LM; Hanes, J; Hartsock, MJ; Kim, YC; Luo, L; Meng, T; Oh, Y; Stark, WJ; Thorne, JE; Xia, S; Xu, Q; Yang, J | 1 |
| McGill, J | 1 |
| Dunne, JA; Gilbert, DJ; Jacobs, N; Morrison, A | 1 |
2 trial(s) available for dexamethasone 21-phosphate and Uveitis
| Article | Year |
|---|---|
The enigma of herpes stromal disease.
Topics: Acyclovir; Administration, Topical; Clinical Trials as Topic; Dexamethasone; Double-Blind Method; Herpes Zoster Ophthalmicus; Humans; Keratitis, Dendritic; Recurrence; Uveitis; Vidarabine; Virus Replication | 1987 |
Efficacy in anterior uveitis of two known steroids and topical tolmetin.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Clinical Trials as Topic; Dexamethasone; Female; Humans; Intraocular Pressure; Male; Middle Aged; Prednisolone; Pyrroles; Tolmetin; Uveitis | 1985 |
1 other study(ies) available for dexamethasone 21-phosphate and Uveitis
| Article | Year |
|---|---|
Controlled release of corticosteroid with biodegradable nanoparticles for treating experimental autoimmune uveitis.
Topics: Administration, Ophthalmic; Adrenal Cortex Hormones; Animals; Autoimmune Diseases; Cytokines; Delayed-Action Preparations; Dexamethasone; Eye; Female; Microglia; Nanoparticles; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Rats, Inbred Lew; Uveitis; Zinc | 2019 |